<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Exp Ther Med</journal-id><journal-id journal-id-type="iso-abbrev">Exp Ther Med</journal-id><journal-id journal-id-type="publisher-id">ETM</journal-id><journal-title-group><journal-title>Experimental and Therapeutic Medicine</journal-title></journal-title-group><issn pub-type="ppub">1792-0981</issn><issn pub-type="epub">1792-1015</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26889218</article-id><article-id pub-id-type="pmc">4726897</article-id><article-id pub-id-type="doi">10.3892/etm.2015.2844</article-id><article-id pub-id-type="publisher-id">ETM-0-0-2844</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Laryngeal mask airway without muscle relaxant in femoral head replacement in elderly patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>KONG</surname><given-names>MING</given-names></name><xref ref-type="aff" rid="af1-etm-0-0-2844"/><xref rid="fn1-etm-0-0-2844" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>LI</surname><given-names>BEIPING</given-names></name><xref ref-type="aff" rid="af1-etm-0-0-2844"/><xref rid="fn1-etm-0-0-2844" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>TIAN</surname><given-names>YUNPING</given-names></name><xref ref-type="aff" rid="af1-etm-0-0-2844"/><xref rid="c1-etm-0-0-2844" ref-type="corresp"/></contrib></contrib-group><aff id="af1-etm-0-0-2844">Department of Anesthesiology, First People's Hospital of Xuzhou, Xuzhou, Jiangsu 221002, P.R. China</aff><author-notes><corresp id="c1-etm-0-0-2844"><italic>Correspondence to</italic>: Yunping Tian, Department of Anesthesiology, First People's Hospital of Xuzhou, 19 Zhongshanbei Road, Xuzhou, Jiangsu 221002, P.R. China, E-mail: <email>typing326@163.com</email></corresp><fn id="fn1-etm-0-0-2844"><label>*</label><p>Contributed equally</p></fn></author-notes><pub-date pub-type="ppub"><month>1</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>09</day><month>11</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>09</day><month>11</month><year>2015</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>11</volume><issue>1</issue><fpage>65</fpage><lpage>68</lpage><history><date date-type="received"><day>21</day><month>8</month><year>2015</year></date><date date-type="accepted"><day>05</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Kong et al.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><p>The number of elderly patients undergoing femoral head replacement surgeries is on the increase. These patients often suffer from comorbidity such as cardiovascular and cerebrovascular complications, which limits the ability of medical teams to employ anesthesia. Thus, alternative methods are required. The aim of this study was to examine the advantage of laryngeal mask airway (LMA) in the absence of muscle relaxant in elderly patients undergoing femoral head replacement operations. Fifty patients (27 males and 23 females) undergoing femoral head replacements were selected for the study between March 2013 and May 2014. The mean value for the age in this group was 74.6&#x000b1;12.5 years. The patients were randomly distributed into two groups of 25. One group was designated as the treatment group and the second group as the control group. For the treatment group, LMA without muscle relaxant was used, and the control group received routine anesthesia. Variations in heart rate (HR), mean arterial pressure (MAP) and oxygen saturation (SPO<sub>2</sub>) in the two groups were monitored at different times. Clinical efficacy and muscle relaxation effects were also analyzed. For the treatment group, the HR, MAP and SPO<sub>2</sub> measurements did not reveal any significant variation while these values in the control group demonstrated important dissimilarities. Time to recovery, time to extubation and incidence of throat pain in the treatment group were all markedly decreased as compared to those in control group. The operation time in the treatment group was not significantly different to that of control group. The satisfaction of the muscle relaxation effect in the treatment group was significantly higher than that in the control group while the incidence of adverse reactions was not considerably different. In conclusion, the use of LMA without using muscle relaxant in femoral head replacement surgeries performed on elderly patients showed to be effective and safe.</p></abstract><kwd-group><kwd>laryngeal mask airway</kwd><kwd>no-muscle-relaxant technology</kwd><kwd>femoral head replacement</kwd><kwd>elderly patients</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The number of elderly patients undergoing femoral head replacement surgeries is on the increase. These patients often suffer from comorbidity such as cardiovascular and cerebrovascular complications, which limits the ability of medical teams to utilize anesthesia (<xref rid="b1-etm-0-0-2844" ref-type="bibr">1</xref>). Inappropriate anesthesia is the main source of severe damage and comorbidity in 12.3% of cases undergoing femoral head replacement surgeries (<xref rid="b2-etm-0-0-2844" ref-type="bibr">2</xref>).</p><p>The introduction of laryngeal mask airway (LMA) by Brain (<xref rid="b3-etm-0-0-2844" ref-type="bibr">3</xref>) replaced the mask and endotracheal intubation and changed the traditional concept of airway management. At present, a 30&#x02013;60% laryngeal mask is applied in general anesthesia. However, the application rate at the Queen Elizabeth Hospital (Hongkong, China) was identified as ~20% (<xref rid="b4-etm-0-0-2844" ref-type="bibr">4</xref>). LMA is considered convenient due to its easier airway maintenance, less gas leakage, and less pollution of the operating room. For patients undergoing a short-duration operation, LMA can replace the bag-mask device (<xref rid="b5-etm-0-0-2844" ref-type="bibr">5</xref>,<xref rid="b6-etm-0-0-2844" ref-type="bibr">6</xref>). Clinical anesthesia induction is often performed under the premise of muscle relaxation, and muscle relaxation is primarily used to reduce the tracheal intubation response and muscle tension during general anesthesia, in order to provide suitable conditions for the operation. However, for patients with myasthenia gravis, obesity, sleep apnea syndrome and other complications, the use of a muscle relaxation agent is a debatable point (<xref rid="b7-etm-0-0-2844" ref-type="bibr">7</xref>,<xref rid="b8-etm-0-0-2844" ref-type="bibr">8</xref>). At the same time, the use of muscle relaxation for minor surgery may affect the patient's recovery and delay the patient's respiratory recovery time (<xref rid="b9-etm-0-0-2844" ref-type="bibr">9</xref>). Laryngeal mask without muscle relaxant has been used in tumor removal, with a favourable outcome (<xref rid="b10-etm-0-0-2844" ref-type="bibr">10</xref>). In the present study, 50 cases of senile patients with femoral head replacement surgery were treated with LMA without muscle relaxant, resulting in a satisfactory effect outcome.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title/><sec><title>General information</title><p>Fifty patients (27 males and 23 females) undergoing femoral head replacements were selected for the study between March 2013 and May 2014.</p><p>The patients were randomly distributed into two groups of 25. One group was designated as the treatment group and the second group served as the control group. Fifteen male and 10 female patients with an age range of 60&#x02013;89 years (74.3&#x000b1;15.2 years) were placed in the treatment group. The mean value for the weight in this group was 53.6&#x000b1;11.3 kg. The control group comprised 12 males and 13 females with an age range of 61&#x02013;88 years (75.4&#x000b1;12.6 years). The mean value for the weight in this group was 52.8&#x000b1;10.7 kg. Gender, age and weight of the patients did not significantly affected the results (P&#x0003e;0.05).</p><p>Inclusion criteria for the study required that each patient undergo examinations prior to surgery and had no anesthesia contraindication in the vertebral canal. Any patients with comorbidity received medical therapy to meet surgical requirements. Liver and renal functions as well as the coagulation function were measured after recovery.</p><p>Exclusion criteria for the current study were: i) Presence of any form of allergy to anesthetics; ii) existence of any type of endocrine disorders; iii) existence of any severe anemia prior to surgery including blood transfusion or blood loss of &#x0003e;500 ml.</p><p>Thirty minutes prior to anesthesia, each patient received 1 mg of penehyclidine hydrochloride intravenously. A hemodynamic monitor (Mindray, Shenzhen, China) was used to monitor the electrocardiogram, oxygen saturation (SPO<sub>2</sub>) and mean arterial pressure (MAP). Sufentanil (0.2 &#x000b5;g/kg), propofol (2 mg/kg) and etomidate (0.3 mg/kg) were used for the treatment group. Opler no. 4 LMA (Vitaltec, Taichung, Taiwan) was inserted following completion of anesthesia. In those cases where the insertion failed twice, LMA was replaced with a tracheal catheter, and the patients were excluded from the treatment group. Criteria established for LMA positioning were: i) bilateral breath sound was required to be similar to that of prior to surgery with no succussion splash into the stomach; ii) peak end tidal CO<sub>2</sub> level (PETCO<sub>2</sub>) was required to be normal; iii) fiberoptic bronchoscopy test was performed.</p><p>For the control group, atracurium (2 mg/kg), sufentanil (0.2 &#x000b5;g/kg) and propofol (0.6 mg/kg) were prepared. Subsequently, a tracheal catheter (diameter 7.0 mm) was intubated and sufentanil (0.1 &#x000b5;g/kg/h) and propofol (4&#x02013;8 mg/kg/h) were administered by continuous intravenous infusion, while atracurium was administered by intermittent intravenous infusion. Patients in the treatment and control groups were subjected to mechanical ventilation. Following completion of the surgeries the patients were subjected to a head lift of &#x0003e;5 sec and breathing for 5 min (SPO<sub>2</sub>&#x02265;95%) in order to regain consciousness. After extubation (withdrawal of LMA) or removal of the tracheal catheter, the patients were returned to the ward.</p></sec><sec><title>Monitoring measurements</title><p>Values for MAP, heart rate (HR) and SPO<sub>2</sub> were recorded at different times: i) prior to anesthesia (T0), ii) immediately after intubation or indwelling of LMA (T1), iii) 10 min after intubation (T2), and iv) immediately after extubation or withdrawal of LMA (T3). Time to recovery, time to extubation, and frequency of postoperative throat pain were also recorded. Muscle relaxation was compared in patients in the two groups.</p></sec><sec><title>Statistical analysis</title><p>Statistical analysis was performed using SPSS 18.0 software. Categorical data were presented by numbers and percentages, and tested using the &#x003c7;<sup>2</sup> test. Quantitative data were presented by means &#x000b1; SD. Inter-group differences were analyzed using the t-test, and analysis of variance was performed between the groups. P&#x0003c;0.05 indicated a statistically significant result.</p></sec></sec></sec><sec sec-type="results"><title>Results</title><sec><title/><sec><title>MAP, HR and SPO<sub>2</sub> measurements at different times</title><p>The results of the monitoring of MAP, HR and SPO<sub>2</sub> in the treatment and control groups prior to surgery did not demonstrate any significant difference (P&#x0003e;0.05). The results of monitoring MAP, HR and SPO<sub>2</sub> indicated that routine anesthesia used for patients in the control group was potentially the source of the instability observed in MAP, HR and SPO<sub>2</sub>. MAP, HR and SPO<sub>2</sub> values in the control group observed at different times were significantly different (HR, F=2.301, P=0.042; MAP, F=2.643, P=0.036; SP0<sub>2</sub>, F=1.955, P=0.044). By contrast, the MAP, HR and SPO<sub>2</sub> values for the patients in the treatment group were not significantly different (P&#x0003e;0.05). This result suggested that LMA without muscle relaxant in the treatment group resulted in a stable MAP, HR and SPO<sub>2</sub> (<xref rid="tI-etm-0-0-2844" ref-type="table">Table I</xref>).</p></sec><sec><title>Clinical efficacy</title><p>Time to recovery, time to extubation and occurrence of throat pain in the treatment group were significantly less than those observed in the control group (P&#x0003c;0.05). The operation time for the treatment group was not significantly different compared to the control group (P&#x0003e;0.05) (<xref rid="tII-etm-0-0-2844" ref-type="table">Table II</xref>).</p></sec><sec><title>Muscle relaxation effect, adjuvant medications and incidence of adverse reaction</title><p>The muscle relaxation effect, adjuvant medications and incidence of adverse reaction for the treatment group were significantly higher than those observed in the control group (&#x003c7;<sup>2</sup>=3.231, P=0.022). Three patients in the treatment group (12.00%) received a combination of innovar and midazolam due to poor anesthesia, which was markedly lower than the number of patients in the control group that required the same intervention. In the control group, 11 patients (44.00%) received a combination of innovar and midazolam, which was significantly higher than the values observed in the treatment group (&#x003c7;<sup>2</sup>=2.424, P=0.035). No patient in either group suffered from severe comorbidity such as arrhythmia at the time of operation. While 3 patients in the treatment group (12.00%) and 4 patients in the control group (16.00%) suffered from nausea and vomiting, the incidence of adverse reactions between two groups was not statistically different (P&#x0003e;0.05) (<xref rid="tIII-etm-0-0-2844" ref-type="table">Table III</xref>).</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Femoral neck fractures are common in the elderly. The majority of patients undergoing femoral head replacements are at risk for respiratory and circulatory comorbidity and massive hemorrhage (<xref rid="b10-etm-0-0-2844" ref-type="bibr">10</xref>). The elderly patients are often in the risk group for multi-system disorders and anesthesia complications due to age-associated reduced physiological functions (<xref rid="b6-etm-0-0-2844" ref-type="bibr">6</xref>). The surgical risk in these patients is also increased due to poor vascular compensation as well as qualitative and quantitative details of intraoperative medications (<xref rid="b5-etm-0-0-2844" ref-type="bibr">5</xref>). Consequently, methods of anesthesia should be selected diligently for these patients. The use of LMA without muscle relaxant can be considered as an ideal method of anesthesia in femoral head replacement surgeries for elderly patients. This method offers a good balance between the efficiency and the safety. In addition, use of this method can reduce the intraoperative instability of blood pressure and HR (<xref rid="b6-etm-0-0-2844" ref-type="bibr">6</xref>&#x02013;<xref rid="b8-etm-0-0-2844" ref-type="bibr">8</xref>). SLIPA LMA is an advanced supraglottic ventilation device similar to human pharyngeal anatomical structure. The absence of air charge cell in SLIPA LMA can prevent recurrent laryngeal nerve injuries caused by the dilatation of the upper esophagus (<xref rid="b2-etm-0-0-2844" ref-type="bibr">2</xref>,<xref rid="b11-etm-0-0-2844" ref-type="bibr">11</xref>). This anesthetic procedure is convenient in clinic and has a relatively high success rate. Intubation of trachea cannula is often complicated and the indwelling of laryngoscope may irritate the glottis and trachea, and can result in hemodynamic changes (<xref rid="b6-etm-0-0-2844" ref-type="bibr">6</xref>,<xref rid="b12-etm-0-0-2844" ref-type="bibr">12</xref>). In this study, all the patients successfully completed the indwelling and we demonstrated that stable HR, MAP and SPO<sub>2</sub> can be obtained using LMA without muscle relaxant.</p><p>No significant differences were identified in the HR, MAP and SPO<sub>2</sub> values at different times in patients in the treatment group. This finding was associated with the fact that laryngoscope was not directly indwelled in LMA. Thus, the vocal cord and tracheal mucosa were not affected, and the sympathetic nerve was not excessively stimulated (<xref rid="b13-etm-0-0-2844" ref-type="bibr">13</xref>,<xref rid="b14-etm-0-0-2844" ref-type="bibr">14</xref>). Furthermore, compared with the results of earlier studies, the time to recovery and time to extubation were decreased for the patients in the treatment group compared to those in the control group (<xref rid="b15-etm-0-0-2844" ref-type="bibr">15</xref>). The incidences of throat pain for patients in the treatment group were inferior to those of the control group, which was consistent with previously reported studies (<xref rid="b16-etm-0-0-2844" ref-type="bibr">16</xref>). These results may be attributed to the fact that indwelling of SLIPA LMA requires no air inflation and may not produce overcompression to the throat cavity wall (<xref rid="b4-etm-0-0-2844" ref-type="bibr">4</xref>,<xref rid="b17-etm-0-0-2844" ref-type="bibr">17</xref>). Although SLIPA LMA required no air inflation, it contained a 50-ml cavity for secretion in order to prevent error aspiration (<xref rid="b18-etm-0-0-2844" ref-type="bibr">18</xref>,<xref rid="b19-etm-0-0-2844" ref-type="bibr">19</xref>). Of note, the use of SLIPA LMA in patients with full or residual stomach contents should be considered prudently (<xref rid="b20-etm-0-0-2844" ref-type="bibr">20</xref>).</p><p>In conclusion, the method of using the SLIPA LMA without muscle relaxant in femoral head replacement surgeries is a superior method that offers stable hemodynamics, postoperative consciousness, early extubation and less throat pain in elderly patients.</p></sec></body><back><ref-list><title>References</title><ref id="b1-etm-0-0-2844"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleisher</surname><given-names>LA</given-names></name></person-group><article-title>Geriatric anesthesia: can we achieve the goal of returning our elderly to the baseline or improved function?</article-title><source>Anesthesiol Clin</source><volume>33</volume><fpage>xiii</fpage><lpage>xiv</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.anclin.2015.06.002</pub-id><pub-id pub-id-type="pmid">26315641</pub-id></element-citation></ref><ref id="b2-etm-0-0-2844"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>T</given-names></name><name><surname>Hase</surname><given-names>I</given-names></name><name><surname>Nishikawa</surname><given-names>K</given-names></name><name><surname>Asada</surname><given-names>A</given-names></name></person-group><article-title>Nitrous oxide induces paradoxical electroencephalographic changes after tracheal intubation during isoflurane and sevoflurane anesthesia</article-title><source>Anesth Analg</source><volume>102</volume><fpage>1094</fpage><lpage>1102</lpage><year>2006</year><pub-id pub-id-type="doi">10.1213/01.ane.0000198509.55543.d6</pub-id><pub-id pub-id-type="pmid">16551905</pub-id></element-citation></ref><ref id="b3-etm-0-0-2844"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brain</surname><given-names>AI</given-names></name></person-group><article-title>Three cases of difficult intubation to overcome by the laryngeal mask airway</article-title><source>Anesthesia</source><volume>40</volume><fpage>353</fpage><lpage>355</lpage><year>1985</year><pub-id pub-id-type="doi">10.1111/j.1365-2044.1985.tb10788.x</pub-id></element-citation></ref><ref id="b4-etm-0-0-2844"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Dawlatly</surname><given-names>AA</given-names></name></person-group><article-title>Anesthesia for thoracoscopic thymectomy: Modified non-muscle relaxant technique-case reports</article-title><source>Middle East J Anaesthesiol</source><volume>19</volume><fpage>219</fpage><lpage>224</lpage><year>2007</year><pub-id pub-id-type="pmid">17511196</pub-id></element-citation></ref><ref id="b5-etm-0-0-2844"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagshaw</surname><given-names>O</given-names></name></person-group><article-title>A combination of total intravenous anesthesia and thoracic epidural for thymectomy in juvenile myasthenia gravis</article-title><source>Paediatr Anaesth</source><volume>17</volume><fpage>370</fpage><lpage>374</lpage><year>2007</year><pub-id pub-id-type="doi">10.1111/j.1460-9592.2006.02122.x</pub-id><pub-id pub-id-type="pmid">17359407</pub-id></element-citation></ref><ref id="b6-etm-0-0-2844"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Mazrou</surname><given-names>KA</given-names></name><name><surname>Abdullah</surname><given-names>KM</given-names></name><name><surname>ElGammal</surname><given-names>MS</given-names></name><name><surname>Ansari</surname><given-names>RA</given-names></name><name><surname>Turkistani</surname><given-names>A</given-names></name><name><surname>Abdelmeguid</surname><given-names>ME</given-names></name></person-group><article-title>Laryngeal mask airway vs. uncuffed endotracheal tube for nasal and paranasal sinus surgery: Paediatric airway protection</article-title><source>Eur J Anaesthesiol</source><volume>27</volume><fpage>16</fpage><lpage>19</lpage><year>2010</year><pub-id pub-id-type="doi">10.1097/EJA.0b013e32832c5f09</pub-id><pub-id pub-id-type="pmid">19444123</pub-id></element-citation></ref><ref id="b7-etm-0-0-2844"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>DM</given-names></name></person-group><article-title>A proposed classification and scoring system for supraglottic sealing airways: A brief review</article-title><source>Anesth Analg</source><volume>99</volume><fpage>1553</fpage><lpage>1559</lpage><year>2004</year><pub-id pub-id-type="doi">10.1213/01.ANE.0000134798.00069.2B</pub-id><pub-id pub-id-type="pmid">15502064</pub-id></element-citation></ref><ref id="b8-etm-0-0-2844"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>DM</given-names></name><name><surname>Camporota</surname><given-names>L</given-names></name></person-group><article-title>Advantages of ProSeal and SLIPA airways over tracheal tubes for gynecological laparoscopies</article-title><source>Can J Anaesth</source><volume>53</volume><fpage>188</fpage><lpage>193</lpage><year>2006</year><pub-id pub-id-type="doi">10.1007/BF03021826</pub-id><pub-id pub-id-type="pmid">16434761</pub-id></element-citation></ref><ref id="b9-etm-0-0-2844"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledowski</surname><given-names>T</given-names></name></person-group><article-title>Muscle relaxation in laparoscopic surgery: what is the evidence for improved operating conditions and patient outcome? A brief review of the literature</article-title><source>Surg Laparosc Endosc Percutan Tech</source><volume>25</volume><fpage>281</fpage><lpage>285</lpage><year>2015</year><pub-id pub-id-type="doi">10.1097/SLE.0000000000000164</pub-id><pub-id pub-id-type="pmid">26121545</pub-id></element-citation></ref><ref id="b10-etm-0-0-2844"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Joo</surname><given-names>JH</given-names></name></person-group><article-title>Total hip replacement with a short metaphyseal-fitting anatomical cementless femoral component in patients aged 70 years or older</article-title><source>J Bone Joint Surg Br</source><volume>93</volume><fpage>587</fpage><lpage>592</lpage><year>2011</year><pub-id pub-id-type="doi">10.1302/0301-620X.93B5.25994</pub-id><pub-id pub-id-type="pmid">21511922</pub-id></element-citation></ref><ref id="b11-etm-0-0-2844"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooshangi</surname><given-names>H</given-names></name><name><surname>Wong</surname><given-names>DT</given-names></name></person-group><article-title>Brief review: the Cobra Perilaryngeal Airway (CobraPLA and the Streamlined Liner of Pharyngeal Airway (SLIPA) supraglottic airways</article-title><source>Can J Anaesth</source><volume>55</volume><fpage>177</fpage><lpage>185</lpage><year>2008</year><pub-id pub-id-type="doi">10.1007/BF03016093</pub-id><pub-id pub-id-type="pmid">18310629</pub-id></element-citation></ref><ref id="b12-etm-0-0-2844"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokee</surname><given-names>N</given-names></name><name><surname>Wiwanitkit</surname><given-names>V</given-names></name></person-group><article-title>Thiopentone sodium and propofol for facilitation of laryngeal mask airway insertion</article-title><source>Ann Afr Med</source><volume>14</volume><fpage>160</fpage><lpage>161</lpage><year>2015</year><pub-id pub-id-type="pmid">26021400</pub-id></element-citation></ref><ref id="b13-etm-0-0-2844"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopinath</surname><given-names>MV</given-names></name><name><surname>Ravishankar</surname><given-names>M</given-names></name><name><surname>Nag</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>VH</given-names></name><name><surname>Velraj</surname><given-names>J</given-names></name><name><surname>Parthasarathy</surname><given-names>S</given-names></name></person-group><article-title>Estimation of effect-site concentration of propofol for laryngeal mask airway insertion using fentanyl or morphine as adjuvant</article-title><source>Indian J Anaesth</source><volume>59</volume><fpage>295</fpage><lpage>299</lpage><year>2015</year><pub-id pub-id-type="doi">10.4103/0019-5049.156874</pub-id><pub-id pub-id-type="pmid">26019354</pub-id></element-citation></ref><ref id="b14-etm-0-0-2844"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nisi</surname><given-names>F</given-names></name><name><surname>Galzerano</surname><given-names>A</given-names></name><name><surname>Cicchitto</surname><given-names>G</given-names></name><name><surname>Puma</surname><given-names>F</given-names></name><name><surname>Peduto</surname><given-names>VA</given-names></name></person-group><article-title>Improving patient safety after rigid bronchoscopy in adults: Laryngeal mask airway versus face mask - a pilot study</article-title><source>Med Devices (Auckl)</source><volume>8</volume><fpage>201</fpage><lpage>206</lpage><year>2015</year><pub-id pub-id-type="doi">10.2147/MDER.S77995</pub-id><pub-id pub-id-type="pmid">25995652</pub-id></element-citation></ref><ref id="b15-etm-0-0-2844"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>TM</given-names></name><name><surname>Kelly</surname><given-names>FE</given-names></name></person-group><article-title>Time to abandon the &#x02018;vintage&#x02019; laryngeal mask airway and adopt second-generation supraglottic airway devices as first choice</article-title><source>Br J Anaesth</source><volume>14</volume><fpage>136</fpage><lpage>137</lpage><year>2015</year><pub-id pub-id-type="pmid">25296912</pub-id></element-citation></ref><ref id="b16-etm-0-0-2844"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanoubi</surname><given-names>I</given-names></name><name><surname>Sun</surname><given-names>JN</given-names></name><name><surname>Drolet</surname><given-names>P</given-names></name><name><surname>Fortier</surname><given-names>LP</given-names></name><name><surname>Donati</surname><given-names>F</given-names></name></person-group><article-title>Replacing a double-lumen tube with a single-lumen tube or a laryngeal mask airway device to reduce coughing at emergence after thoracic surgery: A randomized controlled single-blind trial</article-title><source>Can J Anaesth</source><volume>62</volume><fpage>988</fpage><lpage>995</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s12630-015-0403-2</pub-id><pub-id pub-id-type="pmid">25985845</pub-id></element-citation></ref><ref id="b17-etm-0-0-2844"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baftiu</surname><given-names>N</given-names></name><name><surname>Hadri</surname><given-names>B</given-names></name><name><surname>Morina</surname><given-names>M</given-names></name><name><surname>Mustafa</surname><given-names>A</given-names></name></person-group><article-title>Anesthesia for trans-sternal thymectomy: Modified non-muscle relaxant technique</article-title><source>Med Arh</source><volume>65</volume><fpage>317</fpage><lpage>318</lpage><year>2011</year><pub-id pub-id-type="doi">10.5455/medarh.2011.65.317-318</pub-id><pub-id pub-id-type="pmid">22073861</pub-id></element-citation></ref><ref id="b18-etm-0-0-2844"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortosa</surname><given-names>JA</given-names></name><name><surname>H&#x000e9;rn&#x000e1;ndez-Palaz&#x000f3;n</surname><given-names>J</given-names></name></person-group><article-title>Anaesthesia for laparoscopic cholecystectomy in myasthenia gravis: A non-muscle relaxant technique</article-title><source>Anaesthesia</source><volume>52</volume><fpage>807</fpage><lpage>808</lpage><year>1997</year><pub-id pub-id-type="pmid">9291787</pub-id></element-citation></ref><ref id="b19-etm-0-0-2844"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>MT</given-names></name><name><surname>Ng</surname><given-names>SK</given-names></name><name><surname>Low</surname><given-names>JM</given-names></name></person-group><article-title>A non-muscle-relaxant technique for video-assisted thoracoscopic thymectomy in myasthenia gravis</article-title><source>Anaesth Intensive Care</source><volume>23</volume><fpage>256</fpage><lpage>257</lpage><year>1995</year><pub-id pub-id-type="pmid">7793612</pub-id></element-citation></ref><ref id="b20-etm-0-0-2844"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>el-Dawlatly</surname><given-names>AA</given-names></name><name><surname>Ashour</surname><given-names>MH</given-names></name></person-group><article-title>Anaesthesia for thymectomy in myasthenia gravis: A non-muscle-relaxant technique</article-title><source>Anaesth Intensive Care</source><volume>22</volume><fpage>458</fpage><lpage>460</lpage><year>1994</year><pub-id pub-id-type="pmid">7978212</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tI-etm-0-0-2844" orientation="portrait" position="float"><label>Table I.</label><caption><p>MAP, HR and SPO<sub>2</sub> at different times in the treatment and control groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="2" align="center" valign="bottom" rowspan="1">HR (beat/min)</th><th colspan="2" align="center" valign="bottom" rowspan="1">MAP (mmHg)</th><th colspan="2" align="center" valign="bottom" rowspan="1">SPO<sub>2</sub> (%)</th></tr><tr><th rowspan="1" colspan="1"/><th colspan="2" align="center" valign="bottom" rowspan="1"><hr/></th><th colspan="2" align="center" valign="bottom" rowspan="1"><hr/></th><th colspan="2" align="center" valign="bottom" rowspan="1"><hr/></th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Time</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Treatment</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Treatment</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">Treatment</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">T0</td><td align="center" valign="top" rowspan="1" colspan="1">81.48&#x000b1;10.95</td><td align="center" valign="top" rowspan="1" colspan="1">80.37&#x000b1;10.41</td><td align="center" valign="top" rowspan="1" colspan="1">79.81&#x000b1;9.87</td><td align="center" valign="top" rowspan="1" colspan="1">80.65&#x000b1;8.64</td><td align="center" valign="top" rowspan="1" colspan="1">98.67&#x000b1;1.69</td><td align="center" valign="top" rowspan="1" colspan="1">97.23&#x000b1;1.95</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">T1</td><td align="center" valign="top" rowspan="1" colspan="1">73.32&#x000b1;11.56</td><td align="center" valign="top" rowspan="1" colspan="1">74.58&#x000b1;13.61</td><td align="center" valign="top" rowspan="1" colspan="1">72.41&#x000b1;10.17</td><td align="center" valign="top" rowspan="1" colspan="1">73.37&#x000b1;12.89</td><td align="center" valign="top" rowspan="1" colspan="1">95.01&#x000b1;0.82</td><td align="center" valign="top" rowspan="1" colspan="1">98.00&#x000b1;0.94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">T2</td><td align="center" valign="top" rowspan="1" colspan="1">72.71&#x000b1;10.46</td><td align="center" valign="top" rowspan="1" colspan="1">73.56&#x000b1;12.03</td><td align="center" valign="top" rowspan="1" colspan="1">70.56&#x000b1;10.29</td><td align="center" valign="top" rowspan="1" colspan="1">73.41&#x000b1;10.41</td><td align="center" valign="top" rowspan="1" colspan="1">94.01&#x000b1;0.76</td><td align="center" valign="top" rowspan="1" colspan="1">97.00&#x000b1;0.55</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">T3</td><td align="center" valign="top" rowspan="1" colspan="1">70.08&#x000b1;12.18</td><td align="center" valign="top" rowspan="1" colspan="1">73.48&#x000b1;13.52</td><td align="center" valign="top" rowspan="1" colspan="1">68.55&#x000b1;11.97</td><td align="center" valign="top" rowspan="1" colspan="1">72.52&#x000b1;14.02</td><td align="center" valign="top" rowspan="1" colspan="1">94.19&#x000b1;1.26</td><td align="center" valign="top" rowspan="1" colspan="1">96.52&#x000b1;1.73</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-etm-0-0-2844"><p>HR, heart rate; MAP, mean arterial pressure; SPO<sub>2</sub>, oxygen saturation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tII-etm-0-0-2844" orientation="portrait" position="float"><label>Table II.</label><caption><p>Clinical efficacy in the treatment vs. control group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Group</th><th align="center" valign="bottom" rowspan="1" colspan="1">No.</th><th align="center" valign="bottom" rowspan="1" colspan="1">Time to recovery (min)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Time to extubation (min)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Operation time (min)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Throat pain [number (%)]</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">35.67&#x000b1;16.44</td><td align="center" valign="top" rowspan="1" colspan="1">7.38&#x000b1;2.17</td><td align="center" valign="top" rowspan="1" colspan="1">123.45&#x000b1;46.67</td><td align="center" valign="top" rowspan="1" colspan="1">2 (8.00)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">45.87&#x000b1;20.31</td><td align="center" valign="top" rowspan="1" colspan="1">11.53&#x000b1;3.74</td><td align="center" valign="top" rowspan="1" colspan="1">119.72&#x000b1;36.69</td><td align="center" valign="top" rowspan="1" colspan="1">9 (36.00)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">T (&#x003c7;<sup>2</sup>)</td><td rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">2.854</td><td align="center" valign="top" rowspan="1" colspan="1">3.014</td><td align="center" valign="top" rowspan="1" colspan="1">0.947</td><td align="center" valign="top" rowspan="1" colspan="1">3.947</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P-value</td><td rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.031</td><td align="center" valign="top" rowspan="1" colspan="1">0.026</td><td align="center" valign="top" rowspan="1" colspan="1">0.686</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></table-wrap><table-wrap id="tIII-etm-0-0-2844" orientation="portrait" position="float"><label>Table III.</label><caption><p>Muscle relaxation effect and adjuvant medications in the treatment and control groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="3" align="center" valign="bottom" rowspan="1">Muscle relaxation effect</th><th colspan="2" align="center" valign="bottom" rowspan="1">Adjuvant medications</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="3" align="center" valign="bottom" rowspan="1"><hr/></th><th colspan="2" align="center" valign="bottom" rowspan="1"><hr/></th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Group</th><th align="center" valign="bottom" rowspan="1" colspan="1">Number</th><th align="center" valign="bottom" rowspan="1" colspan="1">Satisfactory (n/%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Good</th><th align="center" valign="bottom" rowspan="1" colspan="1">Poor</th><th align="center" valign="bottom" rowspan="1" colspan="1">Innovar</th><th align="center" valign="bottom" rowspan="1" colspan="1">Midazolam</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">21 (84.00)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (12.00)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (4.00)</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">14 (56.00)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (32.00)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (12.00)</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr></tbody></table></table-wrap></floats-group></article>